Mark E. Lobatto

3.0k citations

24 papers · 1.6k indexed · h-index 16

Impact in

Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases

Papers in

Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
Immunology and Allergy 3
- Cell Adhesion Molecules Research 3

Co-authors: Willem J. M. Mulder Zahi A. Fayad Valentı́n Fuster Claudia Calcagno Edward A. Fisher Ronald E. Gordon Erik S.G. Stroes David P. Cormode
Journals: Journal of the American College of Cardiology (3 papers)Nature Reviews Drug Discovery (2 papers)Bioconjugate Chemistry (2 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)Annals of Surgery (1 paper)
Partner nations: Netherlands United States France

In The Last Decade

Mark E. Lobatto

23 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mark E. Lobatto

Since Specialization

Citations

This map shows the geographic impact of Mark E. Lobatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Lobatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Lobatto more than expected).

Fields of papers citing papers by Mark E. Lobatto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Lobatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Lobatto. The network helps show where Mark E. Lobatto may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Lobatto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Lobatto Line = papers co-authored together Mark E. Lobatto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Late Complication in a Surgically Corrected ALCAPA Patient JACC Case Reports ·Pascal C. Visser, Mitran Keijzers, Ronak Delewi, Mark E. Lobatto, Pieter T. Bot	2022	0
2	Multimodal Positron Emission Tomography Imaging to Quantify Uptake of ⁸⁹Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall Bioconjugate Chemistry ·Mark E. Lobatto, Tina Binderup, Philip M. Robson, Luuk Giesen, Claudia Calcagno, Julia J. Witjes, François Fay, Samantha Baxter, Chang Ho Wessel, Mootaz Eldib, Jason Bini, Sean Carlin, Erik S.G. Stroes, Gert Storm, Andreas Kjær, Jason S. Lewis, Thomas Reiner, Zahi A. Fayad, Willem J. M. Mulder, Carlos Pérez‐Medina	2019	27
3	Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits Methods in molecular biology ·Max L. Senders, Mark E. Lobatto, Raphaël Soler, Olivier Lairez, Carlos Pérez‐Medina, Claudia Calcagno, Zahi A. Fayad, Willem J. M. Mulder, François Fay	2018	2
4	PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis Journal of the American College of Cardiology ·Max L. Senders, Xuchu Que, Young Seok Cho, Calvin Yeang, Hannah Groenen, François Fay, Claudia Calcagno, Anu E. Meerwaldt, Simone Green, Phuong Miu, Mark E. Lobatto, Thomas Reiner, Zahi A. Fayad, Joseph L. Witztum, Willem J. M. Mulder, Carlos Pérez‐Medina, Sotirios Tsimikas	2018	34
5	Multimodal PET imaging of high-density lipoprotein's trafficking in multiple atherosclerosis models Carlos Pérez‐Medina, Tina Binderup, Mark E. Lobatto, Samantha Baxter, Claudia Calcagno, Seigo Ishino, Thomas Reiner, Jason S. Lewis, Zahi A. Fayad, Willem J. M. Mulder	2016	1
6	Atherosclerotic Plaque Targeting Mechanism of Long-Circulating Nanoparticles Established by Multimodal Imaging ACS Nano ·Mark E. Lobatto, Claudia Calcagno, Antoine Millon, Max L. Senders, François Fay, Philip M. Robson, Sarayu Ramachandran, Tina Binderup, Maarten P.M. Paridaans, Steven Sensarn, Stephan Rogalla, Ronald E. Gordon, Luís Cardoso, Gert Storm, Josbert M. Metselaar, Christopher H. Contag, Erik S.G. Stroes, Zahi A. Fayad, Willem J. M. Mulder	2015	102
7	Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy Nanomedicine Nanotechnology Biology and Medicine ·Mark E. Lobatto, Claudia Calcagno, Maarten J. Otten, Antoine Millon, Sarayu Ramachandran, Maarten P.M. Paridaans, Fleur M. van der Valk, Gert Storm, Erik S.G. Stroes, Zahi A. Fayad, Willem J. M. Mulder, Josbert M. Metselaar	2015	36
8	Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration Nanomedicine Nanotechnology Biology and Medicine ·Fleur M. van der Valk, Diederik F. van Wijk, Mark E. Lobatto, Hein J. Verberne, Gert Storm, M.C. Willems, D.A. Legemate, Aart J. Nederveen, Claudia Calcagno, Venkatesh Mani, Sarayu Ramachandran, Maarten P.M. Paridaans, Maarten J. Otten, Geesje M. Dallinga‐Thie, Zahi A. Fayad, Max Nieuwdorp, Dominik M. Schulte, Josbert M. Metselaar, Willem J. M. Mulder, Erik S.G. Stroes	2015	128
9	Targeted liposomal drug delivery to inhibit atherosclerotic plaque inflammation Atherosclerosis ·Amr Alaarg, Anouk A.J. Hamers, Miranda Versloot, Mark E. Lobatto, Willem J. M. Mulder, Erik S.G. Stroes, G. Storm, Josbert M. Metselaar	2015	4
10	HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages Bioconjugate Chemistry ·Brenda L. Sánchez-Gaytán, François Fay, Mark E. Lobatto, Jun Tang, Mireille Ouimet, YongTae Kim, Susanne E. M. van der Staay, Sarian M. van Rijs, Bram Priem, Liangfang Zhang, Edward A. Fisher, Kathryn J. Moore, Róbert Langer, Zahi A. Fayad, Willem J. M. Mulder	2015	129
11	Nonpharmacological Lipoprotein Apheresis Reduces Arterial Inflammation in Familial Hypercholesterolemia Journal of the American College of Cardiology ·Diederik F. van Wijk, Barbara Sjouke, Amparo L. Figueroa, Hamed Emami, Fleur M. van der Valk, Megan H. MacNabb, Linda Hemphill, Dominik M. Schulte, M. G. Koopman, Mark E. Lobatto, Hein J. Verberne, Zahi A. Fayad, John J.P. Kastelein, Willem J. M. Mulder, G. Kees Hovingh, Ahmed Tawakol, Erik S.G. Stroes	2014	76
12	Imaging the Efficacy of Anti-Inflammatory Liposomes in a Rabbit Model of Atherosclerosis by Non-Invasive Imaging Methods in enzymology on CD-ROM/Methods in enzymology ·Mark E. Lobatto, Claudia Calcagno, Josbert M. Metselaar, Gert Storm, Erik S.G. Stroes, Zahi A. Fayad, Willem J. M. Mulder	2012	22
13	Radial k-space acquisition improves robustness of MR-based attenuation maps for MR/PET quantification in an animal imaging study of the abdomen Jason Bini, Philip M. Robson, Claudia Calcagno, Antoine Millon, Mark E. Lobatto, Zahi A. Fayad	2012	1
14	Abstract 9601: A Statin-Loaded Nanotherapy Increases Anti-Inflammatory Effects of Statin on Atherosclerosis Circulation ·Jun Tang, Raphaël Duivenvoorden, David Izquierdo‐Garcia, David P. Cormode, Erik S.G. Stroes, Mark E. Lobatto, Emma L. Kuan, Gwendalyn L Randolph, Valentı́n Fuster, Edward A. Fisher, Willem J. M. Mulder	2011	2
15	In Vivo Characterization of a New Abdominal Aortic Aneurysm Mouse Model With Conventional and Molecular Magnetic Resonance Imaging Journal of the American College of Cardiology ·Ahmed Klink, Joeri Heynens, Beatriz Herránz, Mark E. Lobatto, Teresa Arias, Honorius M. H. F. Sanders, Gustav J. Strijkers, Maarten Merkx, Klaas Nicolay, Valentı́n Fuster, Alain Tedgui, Ziad Mallat, Willem J. M. Mulder, Zahi A. Fayad	2011	75
16	Perspectives and opportunities for nanomedicine in the management of atherosclerosis Nature Reviews Drug Discovery ·Mark E. Lobatto, Valentı́n Fuster, Zahi A. Fayad, Willem J. M. Mulder	2011	331
17	Erratum: Perspectives and opportunities for nanomedicine in the management of atherosclerosis Nature Reviews Drug Discovery ·Mark E. Lobatto, Valentı́n Fuster, Zahi A. Fayad, Willem J. M. Mulder	2011	6
18	Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis Molecular Pharmaceutics ·Mark E. Lobatto, Zahi A. Fayad, S. Silvera, Esad Vucic, Claudia Calcagno, Venkatesh Mani, Stephen Dickson, Klaas Nicolay, Manuela Banciu, Raymond M. Schiffelers, Josbert M. Metselaar, Louis van Bloois, Hai-Shan Wu, John T. Fallon, James H.F. Rudd, Valentı́n Fuster, Edward A. Fisher, Gert Storm, Willem J. M. Mulder	2010	128
19	Multimodality nanotracers for cardiovascular applications Nature Clinical Practice Cardiovascular Medicine ·Willem J. M. Mulder, David P. Cormode, Sjoerd Hak, Mark E. Lobatto, S. Silvera, Zahi A. Fayad	2008	33
20	Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform Nano Letters ·David P. Cormode, Torjus Skajaa, Matti M. van Schooneveld, Rolf Koole, Peter A. Jarzyna, Mark E. Lobatto, Claudia Calcagno, Alessandra Barazza, Ronald E. Gordon, Pat Zanzonico, Edward A. Fisher, Zahi A. Fayad, Willem J. M. Mulder	2008	265

About Mark E. Lobatto

Mark E. Lobatto is a scholar working on Biomaterials, Immunology and Allergy, Immunology, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 24 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Atherosclerosis and Cardiovascular Diseases (10 papers), Cardiovascular Disease and Adiposity (4 papers), Protease and Inhibitor Mechanisms (4 papers), Cell Adhesion Molecules Research (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), Cancer, Lipids, and Metabolism (2 papers) and Advanced MRI Techniques and Applications (2 papers). The work is most often cited by research in Biomaterials (531 citations), Immunology (387 citations), Immunology and Allergy (79 citations), Cancer Research (185 citations) and Biomedical Engineering (501 citations). Mark E. Lobatto has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Willem J. M. Mulder, Zahi A. Fayad, Valentı́n Fuster, Claudia Calcagno, Edward A. Fisher, Ronald E. Gordon, Erik S.G. Stroes, David P. Cormode, François Fay and Gert Storm. Their work appears in journals such as Journal of the American College of Cardiology, Nature Reviews Drug Discovery, Bioconjugate Chemistry, Nanomedicine Nanotechnology Biology and Medicine and Annals of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact